AstraZeneca PLC is 7.3x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($286.27 B vs $39.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TEVA | AZN |
|---|---|---|
| Market cap | $39.12 B | $286.27 B |
| US-listed rank | #392 | #45 |
| Revenue (latest FY) | $17.26B | - |
| Net income (latest FY) | $1.41B | - |
| Net margin | 8.2% | - |
| P/E (trailing FY) | 27.7 | - |
| SEC filings | 2,473 | 1,004 |
AstraZeneca PLC is 7.3x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($286.27 B vs $39.12 B).
Full pages: TEVA PHARMACEUTICAL INDUSTRIES LTD and AstraZeneca PLC, or browse the full rankings.